DISCOVER
CORPORATE NEWS
2025 - PR Telemedicine Technologies and Micron Join Forces Under the CRO Alliance 2024 - PR TTelemedicine Technologies & Artialis partner for clinical research innovation - PR Telemedicine Technologies wins BSMA Clinical Trials Supply Chain Award for groundbreaking CleanWeb™-RTSM module - PR Revenues 2023 2023 - PR VisionHM listed at UGAP - PR acquisition of the French start-up CTMA - PR FY2023 Q1 results - PR FY2023 Q2 results - PR TTSA joins 40-Partner Consortium in xShare Initiative 2022 - PR acquisition of the Swiss company DAPSYS - PR BSA AIR - PR new facilities in Laval, France - PR new facilities in Liège, Belgium - PR FY2022 results 2021 - PR acquisition of the Belgian eCRO Lambda-Plus - PR VisionHM listed at UniHA
Contact
Investors relation
OUR STORY,
OUR STRENGTH
Telemedicine Technologies is the publisher of e-Health solutions, market leader in the field of Clinical Research with its CleanWeb™ solution, a secure Internet platform dedicated to the electronic management of clinical trials and registries.
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
December 13, 2025
Mind Health With 53,000 new cases diagnosed each year, lung cancer is the deadliest cancer in France, according to data from the National Cancer Institute. Three-quarters of cases are detected at an advanced stage, which reduces the chances of recovery. The importance of screening is therefore crucial. In this field, the combination of low-dose CT […]
November 27, 2025
Med City News Healthcare quality isn’t improving at scale, despite advances in technology, because many systems treat it as another compliance task rather than a priority. Stephanie Mercado, CEO of the National Association for Healthcare Quality (NAHQ), argued that investing in workforce skills and standardizing roles can drive safer, higher-quality care while delivering measurable cost […]
November 27, 2025
Trial Site News Clinical trial reporting of treatment efficacy is the foundation of public trust in medicine. Yet pharmaceutical companies often report efficacy measured as a relative risk reduction (RRR) while omitting the more relevant absolute risk reduction (ARR). This statistical sleight of hand can make clinically insignificant benefits look spectacular! Consider a simple example A risk is […]